Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd EurocanPlatform Translational Research Course /
Prediction of side-effects of anti-cancer drugs

12th - 16th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.12.15
Views: 1765

Dr Gerard Milano - Centre Antoine Lacassagne, Nice, France

Dr Milano discusses his talk at the 3rd EurocanPlatform Translational Research Course on the prediction of toxicity in cancer management, using pharmacogenetics.

He outlines the possible impacts, including the in the risks of fluoropyrimidines, which are used in colorectal, breast as well as head and neck cancer. He also looks at the next steps in this research, what challenges they face and what the ultimate benefit will be.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation